Passage Bio (PASG): Sotuvning operatsion marjasi

Passage Bio Inc. (PASG) brendining ramzi va logotipi

Passage Bio, Inc. og'ir patologiyalarga chalingan bolalarda miya funksiyalarini tiklash uchun gen terapiyalarini ishlab chiqish orqali daromad keltiradi. Kompaniyaning kirimlari, jumladan, Krabbe kasalligi kabi kam uchraydigan genetik markaziy nerv tizimi buzilishlari uchun terapiyalarning tijoratlashtirilishiga asoslangan. AAV virusli vektorlaridan foydalanadigan innovatsion loyihalar tor yo'nalishlarni monopolizatsiya qilishni maqsad qilgan. GURU.Markets tizimi tomonidan taqdim etilgan asosiy operatsiyalardan olingan foyda ulushi ushbu grafikda aks ettirilgan bo'lib, unda 0.00 darajasi joriy holatni ifodalaydi.

PASG: Passage Bio Corp Operatsion faoliyat rentabelligi 04.07.2022 - 19.11.2026

Passage Bio, Inc. kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:PASG, passagebio.com
Passage Bio Corp tayyor mahsulotlari

Passage Bio, Inc. (PASG) kompaniyasining markaziy nerv tizimi gen terapiyasi bo'yicha ixtisoslashuvi qat'iy budjet intizomini talab etadi, bu esa umumiy daromadga nisbatan foizlar va soliqlar to'lanishidan oldingi foyda ulushini o'lchovchi operatsion foyda marjida aks etgan. Ushbu ko'rsatkichning tendentsiyasi investorlarga boshqaruvning resurslarni taqsimlash samaradorligini baholash imkonini beradi, bunda qarz yuklamasi nazorat ostida qolgan taqdirda, rentabellikning oshishi biznesning fundamental qiymatining ortishi bilan bevosita bog'liqdir.

Passage Bio, Inc. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Sotuvning operatsion marjasi AMLX (Amylyx Pharmaceuticals, Inc.)|Sotuvning operatsion marjasi Trevi Corp TRVI|Operatsion rentabellik praxismedicines.com PRAX|AVXL - Sotuvning operatsion marjasi|CeriBell EEG - Operatsion marja|Sotuvning operatsion rentabelligi prothena.com|Alector Therapeutics (ALEC) - Operatsion rentabellik|Annexon Biosciences Inc. - Operatsion foyda normasi|OMER (Omeros Corp) - Operatsion marja|Operatsion marja neurogene.com|Operatsion marja ACIU|VYGR - Sotuvning operatsion rentabelligi|Operatsion rentabellik Neumora Therapeutics Inc NMRA|Operatsion faoliyat rentabelligi Scilex Holding Co. (SCLX)|TVGN - Operatsion rentabellik|Sotuvning operatsion rentabelligi alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Sotuvning operatsion marjasi|IKT: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Coya (COYA)|VTGN - Sotuvning operatsion rentabelligi|Operatsion marja OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Sotuvning operatsion rentabelligi|cervomed.com - Operatsion marja|Operatsion foyda normasi ATHE (Alterity Therapeutics Limited)|CLNN: Operatsion marja|Sotuvning operatsion marjasi PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Relmada Therapeutics Inc RLMD|Operatsion rentabellik Annovis Bio Corporation (ANVS)|GRCE - Sotuvning operatsion rentabelligi|Operatsion rentabellik Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Sotuvning operatsion rentabelligi|NeuroSense Therapeutics, Ltd. - Operatsion marja|RVPH: Operatsion rentabellik|MTVA: Operatsion marja|NRXS - Operatsion faoliyat rentabelligi|HSDT (Helius Medical Technologies Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi